CTHRC1 and neoplasm: Finally, a set of 11 genes were identified as candidate biomarkers for differentiating between tumor and normal groups among the 8863 DEGs, including STX12, PHF14, ECT2, PRIM2, CENPL, CTHRC1, INHBA, RNFT2, CLSPN, ESM1, and COL10A1.